Biocon declines on reporting 18% fall in Q2 consolidated net profit

22 Oct 2021 Evaluate

Biocon is currently trading at Rs. 330.75, down by 14.35 points or 4.16% from its previous closing of Rs. 345.10 on the BSE.

The scrip opened at Rs. 344.40 and has touched a high and low of Rs. 344.40 and Rs. 328.30 respectively. So far 238397 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 487.70 on 23-Dec-2020 and a 52 week low of Rs. 327.75 on 23-Aug-2021.

Last one week high and low of the scrip stood at Rs. 349.50 and Rs. 328.30 respectively. The current market cap of the company is Rs. 39883.93 crore.

The promoters holding in the company stood at 60.64%, while Institutions and Non-Institutions held 23.18% and 16.18% respectively.

Biocon has reported net loss at Rs 6.60 crore for second quarter ended September 30, 2021 as compared to net profit of Rs 95.00 crore for the same quarter in the previous year. Total income of the company decreased by 32.27% at Rs 405.30 crore for Q2FY22 as compared Rs 598.40 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 18.31% fall in its net profit attributable to shareholders of the company at Rs 138.30 crore for the quarter under review as against net profit of Rs 169.30 crore for the same quarter in the previous year. However, total income of the company increased by 10.20% at Rs 1945.30 crore for Q2FY22 as compared Rs 1765.30 crore for the corresponding quarter previous year.

Biocon Share Price

377.55 -1.50 (-0.40%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×